Abstract:Background: Multiple Sclerosis (MS) is an autoimmune neurodegenerative disease affecting approximately 3 million people globally. Despite rigorous research on MS, aspects of its development and progression remain unclear. Understanding molecular mechanisms underlying MS is crucial to providing insights into disease pathways, identifying potential biomarkers for early diagnosis, and revealing novel therapeutic targets for improved patient outcomes. Methods: We utilized publicly available RNA-seq data (GSE138614) from post-mortem white matter tissues of five donors without any neurological disorder and ten MS patient donors. This data was interrogated for differential gene expression, alternative splicing and single nucleotide variants as well as for functional enrichments in the resulting datasets. Results: A comparison of non-MS white matter (WM) to MS samples yielded differentially expressed genes involved in adaptive immune response, cell communication, and developmental processes. Genes with expression changes positively correlated with tissue inflammation were enriched in the immune system and receptor interaction pathways. Negatively correlated genes were enriched in neurogenesis, nervous system development, and metabolic pathways. Alternatively spliced transcripts between WM and MS lesions included genes that play roles in neurogenesis, myelination, and oligodendrocyte differentiation, such as brain enriched myelin associated protein ( BCAS1 ), discs large MAGUK scaffold protein 1 ( DLG1 ), KH domain containing RNA binding ( QKI ), and myelin basic protein ( MBP ). Our approach to comparing normal appearing WM (NAWM) and active lesion (AL) from one donor and NAWM and chronic active (CA) tissues from two donors, showed that different IgH and IgK gene subfamilies were differentially expressed. We also identified pathways involved in white matter injury repair and remyelination in these tissues. Differentially spliced genes between these lesions were involved in axon and dendrite structure stability. We also identified exon skipping events and spontaneous single nucleotide polymorphisms in membrane associated ring-CH-type finger 1 ( MARCHF1 ), UDP glycosyltransferase 8 ( UGT8 ), and other genes important in autoimmunity and neurodegeneration. Conclusion: Overall, we identified unique genes, pathways, and novel splicing events affecting disease progression that can be further investigated as potential novel drug targets for MS treatment.

Genome Wide Differences of Gene Expression Associated with HLA-DRB1 Genotype in Multiple Sclerosis: a Pilot Study.

Single Nucleotide Polymorphisms in the Regulatory Regions of the HLA-DRB-expressed Genes

Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects.

Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.

Gene Expression Profile in Multiple Sclerosis Patients and Healthy Controls: Identifying Pathways Relevant to Disease

DNA methylation as a mediator of HLA-DRB1*15 : 01 and a protective variant in multiple sclerosis

Dna Methylation As A Mediator Of Hla-Drb1(Star)15:01 And A Protective Variant In Multiple Sclerosis

Contributions of Vitamin D Response Elements and HLA Promoters to Multiple Sclerosis Risk.

The Influence of Non-Hla Gene Polymorphisms and Interactions on Disease Risk in a Western Australian Multiple Sclerosis Cohort

HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS

34. Frequency of HLA-DRB1 Alleles and Disease-Modifying Effects in a Large West Australian Multiple Sclerosis Cohort

The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort.

Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study

Gene-Based Tests of a Genome-Wide Association Study Dataset Highlight Novel Multiple Sclerosis Risk Genes

Multiple Sclerosis Risk Pathways Differ in Caucasian and Chinese Populations

[Association of HLA-DRB1 and -DPB1 Allele Polymorphism with Multiple Sclerosis in Chinese Han Population from Southern Areas].

Combining gene expression microarrays and Mendelian randomization: exploring key immune-related genes in multiple sclerosis

Gene expression and alternative splicing analysis in a large-scale Multiple Sclerosis study

Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability

60. HLA-DRB1 Alleles Are Determinants of Spinal Cord Pathology in Multiple Sclerosis (MS)

HLA-DR Allele Polymorphism and Multiple Sclerosis in Chinese Populations: a Meta-Analysis